This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1wxn
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==Solution structure of APETx2, a specific peptide inhibitor of ASIC3 proton-gated channels== | ==Solution structure of APETx2, a specific peptide inhibitor of ASIC3 proton-gated channels== | ||
| - | <StructureSection load='1wxn' size='340' side='right' caption='[[1wxn | + | <StructureSection load='1wxn' size='340' side='right'caption='[[1wxn]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[1wxn]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[1wxn]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Anthopleura_elegantissima Anthopleura elegantissima]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1WXN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1WXN FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1wxn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1wxn OCA], [https://pdbe.org/1wxn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1wxn RCSB], [https://www.ebi.ac.uk/pdbsum/1wxn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1wxn ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/BDS2_ANTEL BDS2_ANTEL] This toxin potently blocks acid-sensing ion channel ASIC3 homotrimers and heterotrimers containing ASIC3 (composed with isoforms of ASIC1 and ASIC2) (PubMed:15044953). It also weakly inhibits potassium channels, and sodium channels (PubMed:15044953, PubMed:21943094, PubMed:22972919, PubMed:25337890). On homomeric ASIC3, this protein shows IC(50)=57-87 nM on rat, 37.3 nM on mouse and 175 nM on human channels (PubMed:15044953, PubMed:18923424, PubMed:19306891, PubMed:20813121, PubMed:21943094, PubMed:22851922, PubMed:22851929). The blockade is rapid and reversible (PubMed:15044953). On heterotrimeric forms, the toxin is less potent (IC(50)=117 nM on rat ASIC2b-ASIC3 channel, 900 nM on rat ASIC1b-ASIC3, and 2 uM on rat ASIC1a-ASIC3) (PubMed:15044953). It weakly inhibits Kv3.4/KCNC4 potassium channels (3 uM of the toxin inhibits 38% of Kv3.4 current) (PubMed:15044953). It reversibly and voltage-dependently inhibits hKv11.1/KCNH2/ERG1 potassium channels (IC(50)=1.21 uM), inhibiting both peak and tail currents without action on channel inactivation (PubMed:25337890). It weakly inhibits rNav1.2/SCN2A (EC(50)=114 nM), rNav1.6/SCN8A current (17% at 1 uM of the toxin) and Nav1.8/SCN10A (IC(50)=6.6 uM on human channels expressed in oocytes, EC(50)=55 nM on rat channels expressed in oocytes, and 2.6 uM on rat channels in DRG neurons) (PubMed:21943094, PubMed:22972919). It may act on sodium channels by binding at site 1 or close by, when the pore is in an open configuration (PubMed:22972919). In vivo, central injection does not induce neurotoxin symptoms in mice even after 24 hours (PubMed:15044953). However, it abolishes acid-induced pain in rats (PubMed:18923424).<ref>PMID:15044953</ref> <ref>PMID:18923424</ref> <ref>PMID:19306891</ref> <ref>PMID:20813121</ref> <ref>PMID:21943094</ref> <ref>PMID:22851922</ref> <ref>PMID:22851929</ref> <ref>PMID:22972919</ref> <ref>PMID:25337890</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 15: | Line 17: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 1wxn" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 20: | Line 23: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Anthopleura elegantissima]] | [[Category: Anthopleura elegantissima]] | ||
| - | [[Category: Bernard | + | [[Category: Large Structures]] |
| - | [[Category: Chagot | + | [[Category: Bernard C]] |
| - | [[Category: Darbon | + | [[Category: Chagot B]] |
| - | [[Category: Diochot | + | [[Category: Darbon H]] |
| - | [[Category: Escoubas | + | [[Category: Diochot S]] |
| - | [[Category: Lazdunski | + | [[Category: Escoubas P]] |
| - | + | [[Category: Lazdunski M]] | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Solution structure of APETx2, a specific peptide inhibitor of ASIC3 proton-gated channels
| |||||||||||
